KC
BMY icon

Knuff & Co’s Bristol-Myers Squibb BMY Stock Holding History

Knuff & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$985K Buy
16,238
+5,300
+48% +$309K 0.3% 51
2025
Q4 		$590K Buy
10,938
+200
+2% +$9.62K 0.17% 61
2025
Q3 		$484K Sell
10,738
-3,110
-22% -$145K 0.14% 67
2025
Q2 		$641K Sell
13,848
-1,690
-11% -$83K 0.2% 61
2025
Q1 		$948K Buy
15,538
+4,300
+38% +$251K 0.32% 54
2024
Q4 		$636K Hold
11,238
– – 0.19% 70
2024
Q3 		$581K Buy
11,238
+1,350
+14% +$63.3K 0.18% 70
2024
Q2 		$411K Sell
9,888
-510
-5% -$22.8K 0.13% 80
2024
Q1 		$564K Sell
10,398
-400
-4% -$20.4K 0.19% 67
2023
Q4 		$554K Sell
10,798
-5,345
-33% -$281K 0.2% 65
2023
Q3 		$937K Sell
16,143
-650
-4% -$39.8K 0.37% 52
2023
Q2 		$1.07M Sell
16,793
-1,000
-6% -$67.1K 0.4% 52
2023
Q1 		$1.23M Sell
17,793
-620
-3% -$43.7K 0.49% 49
2022
Q4 		$1.32M Hold
18,413
– – 0.56% 46
2022
Q3 		$1.31M Sell
18,413
-875
-5% -$63.5K 0.62% 42
2022
Q2 		$1.49M Hold
19,288
– – 0.67% 41
2022
Q1 		$1.41M Sell
19,288
-4,762
-20% -$320K 0.51% 51
2021
Q4 		$1.5M Buy
24,050
+6,765
+39% +$397K 0.46% 52
2021
Q3 		$1.02M Buy
17,285
+120
+0.7% +$7.9K 0.38% 54
2021
Q2 		$1.15M Hold
17,165
– – 0.43% 54
2021
Q1 		$1.08M Sell
17,165
-6,805
-28% -$423K 0.46% 51
2020
Q4 		$1.49M Sell
23,970
-14,155
-37% -$870K 0.61% 41
2020
Q3 		$2.3M Sell
38,125
-4,097
-10% -$247K 1.08% 32
2020
Q2 		$2.48M Buy
42,222
+3,887
+10% +$232K 1.36% 27
2020
Q1 		$2.14M Buy
38,335
+1,880
+5% +$115K 1.55% 20
2019
Q4 		$2.34M Buy
36,455
+34,040
+1,410% +$1.95M 1.4% 20
2019
Q3 		$122K Buy
2,415
+950
+65% +$44.6K 0.08% 79
2019
Q2 		$66K Buy
1,465
+525
+56% +$24.5K 0.05% 89
2019
Q1 		$45K Hold
940
– – 0.03% 102
2018
Q4 		$49K Buy
+940
New +$50.5K 0.05% 85

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Knuff & Co's BMY Position: Q1 2026 in Review

Knuff & Co increased its Bristol-Myers Squibb (BMY) stake by 48% in Q1 2026, buying an estimated $309K and bringing the position to 16,238 shares worth $985K. The position accounts for 0.3% of the portfolio, ranked #51.

Knuff & Co first reported a position in BMY in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.48M in Q2 2020. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Knuff & Co held 16,238 shares of Bristol-Myers Squibb worth $985K as of Q1 2026.
  • Knuff & Co bought 5,300 Bristol-Myers Squibb shares in Q1 2026, an estimated $309K.
  • Bristol-Myers Squibb made up 0.3% of Knuff & Co's portfolio in Q1 2026, its #51 holding.
  • Knuff & Co first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 30 quarters since.
  • Knuff & Co's Bristol-Myers Squibb position peaked at $2.48M in Q2 2020.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Knuff & Co's 13F filing for Q1 2026, filed 11 May 2026.